191 related articles for article (PubMed ID: 32446169)
1. Enhancing the oral bioavailability of simvastatin with silica-lipid hybrid particles: The effect of supersaturation and silica geometry.
Meola TR; Schultz HB; Peressin KF; Prestidge CA
Eur J Pharm Sci; 2020 Jul; 150():105357. PubMed ID: 32446169
[TBL] [Abstract][Full Text] [Related]
2. A safety, tolerability, and pharmacokinetic study of a novel simvastatin silica-lipid hybrid formulation in healthy male participants.
Meola TR; Abuhelwa AY; Joyce P; Clifton P; Prestidge CA
Drug Deliv Transl Res; 2021 Jun; 11(3):1261-1272. PubMed ID: 32918160
[TBL] [Abstract][Full Text] [Related]
3. Silica-lipid hybrid (SLH) formulations enhance the oral bioavailability and efficacy of celecoxib: An in vivo evaluation.
Nguyen TH; Tan A; Santos L; Ngo D; Edwards GA; Porter CJ; Prestidge CA; Boyd BJ
J Control Release; 2013 Apr; 167(1):85-91. PubMed ID: 23353808
[TBL] [Abstract][Full Text] [Related]
4. Supersaturated-Silica Lipid Hybrids Improve in Vitro Solubilization of Abiraterone Acetate.
Schultz HB; Joyce P; Thomas N; Prestidge CA
Pharm Res; 2020 Mar; 37(4):77. PubMed ID: 32236761
[TBL] [Abstract][Full Text] [Related]
5. Pluronic-Functionalized Silica-Lipid Hybrid Microparticles: Improving the Oral Delivery of Poorly Water-Soluble Weak Bases.
Rao S; Richter K; Nguyen TH; Boyd BJ; Porter CJ; Tan A; Prestidge CA
Mol Pharm; 2015 Dec; 12(12):4424-33. PubMed ID: 26523928
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of abiraterone acetate oral bioavailability by supersaturated-silica lipid hybrids.
Schultz HB; Wignall AD; Thomas N; Prestidge CA
Int J Pharm; 2020 May; 582():119264. PubMed ID: 32278053
[TBL] [Abstract][Full Text] [Related]
7. Supersaturated silica-lipid hybrids (super-SLH): An improved solid-state lipid-based oral drug delivery system with enhanced drug loading.
Schultz HB; Thomas N; Rao S; Prestidge CA
Eur J Pharm Biopharm; 2018 Apr; 125():13-20. PubMed ID: 29277724
[TBL] [Abstract][Full Text] [Related]
8. Synergistic role of self-emulsifying lipids and nanostructured porous silica particles in optimizing the oral delivery of lovastatin.
Rao S; Tan A; Boyd BJ; Prestidge CA
Nanomedicine (Lond); 2014 Dec; 9(18):2745-59. PubMed ID: 24938439
[TBL] [Abstract][Full Text] [Related]
9. Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance.
Schultz HB; Kovalainen M; Peressin KF; Thomas N; Prestidge CA
J Pharmacol Exp Ther; 2019 Sep; 370(3):742-750. PubMed ID: 30552294
[TBL] [Abstract][Full Text] [Related]
10. Lyophilized silica lipid hybrid (SLH) carriers for poorly water-soluble drugs: physicochemical and in vitro pharmaceutical investigations.
Yasmin R; Tan A; Bremmell KE; Prestidge CA
J Pharm Sci; 2014 Sep; 103(9):2950-2959. PubMed ID: 24585389
[TBL] [Abstract][Full Text] [Related]
11. Nanocrystal-silica-lipid hybrid particles for the improved oral delivery of ziprasidone in vitro.
Meola TR; Dening TJ; Prestidge CA
Eur J Pharm Biopharm; 2018 Aug; 129():145-153. PubMed ID: 29857135
[TBL] [Abstract][Full Text] [Related]
12. Silica-lipid hybrid (SLH) versus non-lipid formulations for optimising the dose-dependent oral absorption of celecoxib.
Tan A; Davey AK; Prestidge CA
Pharm Res; 2011 Sep; 28(9):2273-87. PubMed ID: 21560021
[TBL] [Abstract][Full Text] [Related]
13. Self-Emulsifying Drug Delivery System of Simvastatin: Formulation Development, Optimization by Box- Behnken Design,
Verma M; Nanda A; Kumar Y
Recent Pat Drug Deliv Formul; 2018; 12(3):199-211. PubMed ID: 30345934
[TBL] [Abstract][Full Text] [Related]
14. Silica encapsulated lipid-based drug delivery systems for reducing the fed/fasted variations of ziprasidone in vitro.
Dening TJ; Rao S; Thomas N; Prestidge CA
Eur J Pharm Biopharm; 2016 Apr; 101():33-42. PubMed ID: 26812284
[TBL] [Abstract][Full Text] [Related]
15. Highly ordered mesoporous carbon nanomatrix as a new approach to improve the oral absorption of the water-insoluble drug, simvastatin.
Zhang Y; Wang H; Gao C; Li X; Li L
Eur J Pharm Sci; 2013 Aug; 49(5):864-72. PubMed ID: 23791638
[TBL] [Abstract][Full Text] [Related]
16. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.
Tan A; Simovic S; Davey AK; Rades T; Prestidge CA
J Control Release; 2009 Feb; 134(1):62-70. PubMed ID: 19013488
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin.
Fathi HA; Allam A; Elsabahy M; Fetih G; El-Badry M
Colloids Surf B Biointerfaces; 2018 Feb; 162():236-245. PubMed ID: 29197789
[TBL] [Abstract][Full Text] [Related]
18. Synergistic role of solid lipid and porous silica in improving the oral delivery of weakly basic poorly water soluble drugs.
Yasmin R; Rao S; Bremmell K; Prestidge C
Eur J Pharm Sci; 2017 Jan; 96():508-514. PubMed ID: 27793717
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Solidification on the in vitro Solubilisation of Blonanserin Loaded Supersaturated Lipid-Based Oral Formulations.
Møller A; Schultz HB; Meola TR; Müllertz A; Prestidge CA
Eur J Pharm Sci; 2021 Feb; 157():105640. PubMed ID: 33189902
[TBL] [Abstract][Full Text] [Related]
20. Furosemide Loaded Silica-Lipid Hybrid Microparticles: Formulation Development, in vitro and ex vivo Evaluation.
Sambaraj S; Ammula D; Nagabandi V
Adv Pharm Bull; 2015 Sep; 5(3):403-9. PubMed ID: 26504763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
